Silo Pharma, Inc. (SILO)

NASDAQ: SILO · IEX Real-Time Price · USD
1.890
-0.020 (-1.05%)
Mar 28, 2024, 1:48 PM EDT - Market open

Total Valuation

Silo Pharma has a market cap or net worth of $5.51 million. The enterprise value is -$2.15 million.

Market Cap 5.51M
Enterprise Value -2.15M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Silo Pharma has 2.84 million shares outstanding. The number of shares has increased by 34.83% in one year.

Shares Outstanding 2.84M
Shares Change (YoY) +34.83%
Shares Change (QoQ) -6.76%
Owned by Insiders (%) 6.07%
Owned by Institutions (%) 5.65%
Float 2.52M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 76.45
Forward PS 300.23
PB Ratio 0.89
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.90, with zero debt.

Current Ratio 9.90
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -759.05

Financial Efficiency

Return on equity (ROE) is -47.10% and return on invested capital (ROIC) is -62.42%.

Return on Equity (ROE) -47.10%
Return on Assets (ROA) -39.00%
Return on Capital (ROIC) -62.42%
Revenue Per Employee $24,034
Profits Per Employee -$1.23M
Employee Count 3
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -4.98% in the last 52 weeks. The beta is 1.32, so Silo Pharma's price volatility has been higher than the market average.

Beta (1Y) 1.32
52-Week Price Change -4.98%
50-Day Moving Average 1.60
200-Day Moving Average 1.72
Relative Strength Index (RSI) 68.14
Average Volume (30 Days) 101,580

Short Selling Information

The latest short interest is 50,721, so 1.78% of the outstanding shares have been sold short.

Short Interest 50,721
Short Previous Month 49,428
Short % of Shares Out 1.78%
Short % of Float 2.01%
Short Ratio (days to cover) 0.44

Income Statement

In the last 12 months, Silo Pharma had revenue of $72,102 and -$3.70 million in losses. Loss per share was -$1.20.

Revenue 72,102
Gross Profit 66,264
Operating Income -3.86M
Pretax Income -3.70M
Net Income -3.70M
EBITDA -3.70M
EBIT -3.70M
Loss Per Share -$1.20
Full Income Statement

Balance Sheet

The company has $7.67 million in cash and no debt, giving a net cash position of $7.67 million or $2.70 per share.

Cash & Cash Equivalents 7.67M
Total Debt n/a
Net Cash 7.67M
Net Cash Per Share $2.70
Equity / Book Value 6.18M
Book Value Per Share 2.17
Working Capital 6.91M
Full Balance Sheet

Cash Flow

Operating Cash Flow -3.22M
Capital Expenditures n/a
Free Cash Flow -3.22M
FCF Per Share -$1.05
Full Cash Flow Statement

Margins

Gross margin is 91.90%, with operating and profit margins of -5,347.41% and -5,132.57%.

Gross Margin 91.90%
Operating Margin -5,347.41%
Pretax Margin -5,132.57%
Profit Margin -5,132.57%
EBITDA Margin -5,125.81%
EBIT Margin -5,125.81%
FCF Margin -4,472.13%

Dividends & Yields

Silo Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -34.83%
Shareholder Yield -34.83%
Earnings Yield -67.14%
FCF Yield -58.50%

Analyst Forecast

The average price target for Silo Pharma is $10.00, which is 429.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 429.10%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 0.31%
EPS Growth Forecast (5Y) -5.29%
Stock Forecasts

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date Sep 15, 2022
Split Type Reverse
Split Ratio 1:50

Scores

Silo Pharma has an Altman Z-Score of -0.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.35
Piotroski F-Score 2